Innovation
In the 2022/2023 business year, we spent EUR 48 million on research and development
Active Agent Production Renewed
By renewing our active agent base, we wish to simultaneously raise the rate of our active agents produced internally in a reliable quality and at a competitive price as well as to increase our exports.
Other channels
Egis' products are sold to 100 countries.
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
In the 2022/2023 business year, the company’s product portfolio consisted of 653 products
Healthcare and sharing knowledge are in the heart of our CSR activities
Our highlighted past and future events you shouldn't miss
Quick news
Your browser is out of date. Please, use an updated version!